Authors
Latest:
Akanksha Mehta, MD, MS, highlights the residency program at Emory Urology"This year, we are starting an international rotation with a focus on global health and humanitarian work," says Akanksha Mehta, MD, MS.
Latest:
Despite overall gains, leadership and payment gaps remain for women in medicine"The good news is that women have been entering medicine in increasing numbers for more than three decades. The not-so-good news is that women are still underrepresented and underutilized in positions of power," writes Deborah M. Shlian, MD, MBA.
Latest:
EP. 4B: Educating Patients on Their Treatment Options for LG UTUCIn this companion article, Armine K. Smith, MD, reflects on the role of kidney-sparing approaches for LG UTUC and emphasizes the importance of patient-provider communication when making treatment decisions.
Latest:
Expert insight on ransomware: Is your practice prepared?Ransomware has never been a more serious threat for health care organizations, even small medical practices.
Latest:
Closing Thoughts on Urology Practice Management and Treatment of Advanced Prostate CancerClosing out their discussion on how treatment and management of advanced prostate cancer affects their clinical practice, expert urologists consider how the therapeutic landscape continues to evolve and look toward future evolutions in care.
Latest:
How APPs can be involved with genitourinary cancer careA nurse practitioner discusses how she supports multiple providers in a large academic practice.
Latest:
Identifying unique therapeutic targets for chromophobe kidney cancer“What we hope overall is that this is a biological study that might inform therapeutic development for this disease,” says David A. Braun, MD, PhD.
Latest:
Moving transperineal prostate biopsy into the clinicLearning curve for technique is short, but capital expenditures are required.
Latest:
Expert Opinion: We cannot continue to ignore the problem of physician mental distress"We need health systems, state medical boards and physician employment settings to commit to prioritizing physician wellbeing and provide the reassurances and resources that encourage physicians in need to seek help," writes Russell Libby, MD.
Latest:
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
Latest:
Future Directions for Imaging and Biopsy in Prostate CancerThe panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
Latest:
Leilei Xia, MD, on the role of extended lymph node dissection post-S1011 trial"That gave us the idea that the diagnostic benefit of extended lymph node detection was pretty minimal," says Leilei Xia, MD.
Latest:
US Chamber of Commerce asks for delay on non-compete ruleThe request comes amid growing concerns about the rule’s implications for businesses and employees nationwide.
Latest:
Novel dual agents for advanced prostate cancerA recap of presentations from AUA 2021 highlighting next steps using novel therapies as combination approaches to treat advanced prostate cancer.
Latest:
Breakthrough Study in Image-Guided Prostate Cancer TreatmentPublished OPTIMUM Trial results compares high-resolution micro-ultrasound with MRI when considering prostate biopsy.
Latest:
Follow-Up After Negative Bone/CT in Prostate Cancer With Molecular RecurrenceDr Raoul Concepcion leads a multidisciplinary expert panel in a discussion about the challenges of long-term follow-up of prostate cancer in patients with negative bone/CT but positive molecular indicators of recurrence.
Latest:
MRI-based screening emerging as viable alternative to PSA testing“MRI-based screening showed lower proportions of screening-positive cases, lower false positive rates, and higher PPVs [positive predictive values] than those of PSA-based screening,” noted Taek Min Kim, MD.
Latest:
Is greater patient control of their personal health records a plus for physicians?The Cures Act has teeth and consumers are becoming increasingly aware of their right to obtain their information.
Latest:
DFS end point not reached with adjuvant nivolumab for locally advanced high-risk RCCPatient subgroups that favored nivolumab vs placebo included patients with sarcomatoid features (HR, 0.42; 95% CI, 0.17-1.07), PD-L1 expression of 1% or greater (HR, 0.53; 95% CI, 0.22-1.29), and those with lower limit of normal hemoglobin at baseline (HR, 0.49; 95% CI, 0.25-1.49).
Latest:
Moffitt Study Suggests Improvements Needed for Patient-Reported Outcome Data in Genitourinary Cancer Clinical Studies“Our data showed a considerable gap in reporting patient-reported outcomes and in the quality of design and conduct of patient-reported outcomes-related trial endpoints," said Jad Chahoud, MD, MPH.
Latest:
Addressing Remaining Unmet Needs in mCRPCPanelists discuss how future trials in metastatic castration-resistant prostate cancer (mCRPC) should focus on developing reliable biomarker-driven treatment selection strategies to optimize sequencing decisions and identify which patients will benefit most from specific therapies or combinations, particularly as the treatment landscape becomes increasingly complex.
Latest:
Emulating target trials using observational evidence to inform clinical decision-making"The emulation framework lends the design and conduct of observational analyses some of the rigor required for the planning of a randomized trial. In doing so, it provides an innovative and principled approach to improve the evidence base on the comparative effectiveness of interventions," writes Boris Gershman, MD, and Aaron Fleishman, MPH.
Latest:
Ascension cyberattack’s impact felt in multiple statesSome Ascension hospitals continue to divert ambulances to other facilities for emergency treatment, but some of the system’s hospitals are accepting all patients.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
Can remote patient monitoring help combat the staffing shortage?"As more patients become interested in remote patient monitoring and case studies continue to show improved patient outcomes, practices must seek ways to integrate these tools into their workflows," writes Lucienne Marie Ide, MD, PhD.
Latest:
Unmet Needs and Investigational Therapies in mCSPCDr Jason Hafron concludes his discussion of mCSPC by highlighting the need to work towards a cure for the disease, and two major clinical trials investigating triplet treatment regimens.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Chronic care management in the urologic oncology settingCCM programs can engage multiple providers to care for patients while reducing in-person visits.
Latest:
What you need to know about providing telehealth in 2023Jeremy D. Sherer, JD, explains everything physicians need to know about using telemedicine in their practice in 2023.
